# A Novel and Efficient Biochemical Screening Strategy for Glucocorticoid-Remediable Aldosteronism: Combined 1-mg Overnight Dexamethasone Suppression Test and Steroid Profile

> **NCT07700888** · — · COMPLETED · sponsor: **Peking Union Medical College Hospital** · enrollment: 50 (actual)

## Conditions studied

- Primary Aldosteronism
- Primary Aldosteronism Due to Aldosterone Producing Adenoma

## Interventions

- **DIAGNOSTIC_TEST:** 1 mg overnight dexamethasone inhibition test

## Key facts

- **NCT ID:** NCT07700888
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-01
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07700888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07700888, "A Novel and Efficient Biochemical Screening Strategy for Glucocorticoid-Remediable Aldosteronism: Combined 1-mg Overnight Dexamethasone Suppression Test and Steroid Profile". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07700888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*